Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Liang

Showing results (121-130 of 1,938) with videos related to

Pageof 194
Sort By:
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Nonpeptide as Oxytocin Receptor AgonistYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Isoindolinone-Containing PARP Inhibitors: Synthesis and Therapeutic Applications in CNS Cancer TreatmentXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|February 18, 2026
Novel Pyridopyrazine Derivatives as Inverse Agonists of the G Protein-Coupled Receptor 6Yinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|March 19, 2025
Identification of Indazole- and Azaindazole-Substituted Cyclopentapyrroles as G2019S Leucine-Rich Repeat Kinase 2 Inhibitors for the Treatment of CNS DisordersSiyan Feng, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
Novel Pyrazolo[1,5-<i>a</i>]pyrimidine-3,5-diamines as nSMase2 InhibitorsJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|March 18, 2026
Novel Macrocyclic Compounds Targeting KRAS Mutations for Cancer TreatmentLingxin Meng, Steven H Liang
ACS Medicinal Chemistry Letters|March 18, 2026
Novel Epidermal Growth Factor Receptor (EGFR) Exon20 Insertion-Selective Inhibitors for Lung Cancer TherapyYanwei Jiang, Steven H Liang
ACS Medicinal Chemistry Letters|March 18, 2026
Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6Yinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of Novel Benzothiazole-Based PDE4 Inhibitors for Central Nervous System DisordersLingxin Meng, Steven H Liang
ACS Medicinal Chemistry Letters|May 20, 2026
Novel 1‑Phenyl-2,3-dihydroquinazolin-4(1H)-one Derivatives as Na<sub>v</sub> 1.8 Voltage-Gated Sodium Channels InhibitorsRuihu Song, Steven H Liang
Pageof 194

Showing results (121-130 of 1,938) with videos related to

Sort By:
Pageof 194
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Nonpeptide as Oxytocin Receptor AgonistYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Isoindolinone-Containing PARP Inhibitors: Synthesis and Therapeutic Applications in CNS Cancer TreatmentXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|February 18, 2026
Novel Pyridopyrazine Derivatives as Inverse Agonists of the G Protein-Coupled Receptor 6Yinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|March 19, 2025
Identification of Indazole- and Azaindazole-Substituted Cyclopentapyrroles as G2019S Leucine-Rich Repeat Kinase 2 Inhibitors for the Treatment of CNS DisordersSiyan Feng, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
Novel Pyrazolo[1,5-<i>a</i>]pyrimidine-3,5-diamines as nSMase2 InhibitorsJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|March 18, 2026
Novel Macrocyclic Compounds Targeting KRAS Mutations for Cancer TreatmentLingxin Meng, Steven H Liang
ACS Medicinal Chemistry Letters|March 18, 2026
Novel Epidermal Growth Factor Receptor (EGFR) Exon20 Insertion-Selective Inhibitors for Lung Cancer TherapyYanwei Jiang, Steven H Liang
ACS Medicinal Chemistry Letters|March 18, 2026
Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6Yinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of Novel Benzothiazole-Based PDE4 Inhibitors for Central Nervous System DisordersLingxin Meng, Steven H Liang
ACS Medicinal Chemistry Letters|May 20, 2026
Novel 1‑Phenyl-2,3-dihydroquinazolin-4(1H)-one Derivatives as Na<sub>v</sub> 1.8 Voltage-Gated Sodium Channels InhibitorsRuihu Song, Steven H Liang
Pageof 194